Cargando…

Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease

Hereditary hemochromatosis (HH) is an inherited iron overload disorder due to a deficiency of hepcidin, or a failure of hepcidin to degrade ferroportin. The most common form of HH, Type 1 HH, is most commonly due to a homozygous C282Y mutation in HFE and is relatively well understood in significance...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowdley, Devan S, Kowdley, Kris V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369226/
https://www.ncbi.nlm.nih.gov/pubmed/34413666
http://dx.doi.org/10.2147/TACG.S269622
_version_ 1783739248559521792
author Kowdley, Devan S
Kowdley, Kris V
author_facet Kowdley, Devan S
Kowdley, Kris V
author_sort Kowdley, Devan S
collection PubMed
description Hereditary hemochromatosis (HH) is an inherited iron overload disorder due to a deficiency of hepcidin, or a failure of hepcidin to degrade ferroportin. The most common form of HH, Type 1 HH, is most commonly due to a homozygous C282Y mutation in HFE and is relatively well understood in significance and action; however, other rare forms of HH (Types 2–4) exist and are more difficult to identify and diagnose in clinical practice. In this review, we describe the clinical characteristics of HH Type 2–4 and the mutation patterns that have been described in these conditions. We also review the different methods for genetic testing available in clinical practice and a pragmatic approach to the patient with suspected non-HFE HH.
format Online
Article
Text
id pubmed-8369226
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-83692262021-08-18 Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease Kowdley, Devan S Kowdley, Kris V Appl Clin Genet Review Hereditary hemochromatosis (HH) is an inherited iron overload disorder due to a deficiency of hepcidin, or a failure of hepcidin to degrade ferroportin. The most common form of HH, Type 1 HH, is most commonly due to a homozygous C282Y mutation in HFE and is relatively well understood in significance and action; however, other rare forms of HH (Types 2–4) exist and are more difficult to identify and diagnose in clinical practice. In this review, we describe the clinical characteristics of HH Type 2–4 and the mutation patterns that have been described in these conditions. We also review the different methods for genetic testing available in clinical practice and a pragmatic approach to the patient with suspected non-HFE HH. Dove 2021-08-12 /pmc/articles/PMC8369226/ /pubmed/34413666 http://dx.doi.org/10.2147/TACG.S269622 Text en © 2021 Kowdley and Kowdley. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Kowdley, Devan S
Kowdley, Kris V
Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease
title Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease
title_full Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease
title_fullStr Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease
title_full_unstemmed Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease
title_short Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease
title_sort appropriate clinical genetic testing of hemochromatosis type 2–4, including ferroportin disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369226/
https://www.ncbi.nlm.nih.gov/pubmed/34413666
http://dx.doi.org/10.2147/TACG.S269622
work_keys_str_mv AT kowdleydevans appropriateclinicalgenetictestingofhemochromatosistype24includingferroportindisease
AT kowdleykrisv appropriateclinicalgenetictestingofhemochromatosistype24includingferroportindisease